Beijing Tong Ren Tang Chinese Medicine Company (3613) Q1 2025 earnings summary

Executive summary

• Announcement discloses that unaudited financial information for the three months ended 31 March 2025 has been published by the controlling shareholder, Tong Ren Tang Technologies.

• Reference is made to further unaudited results to be announced by the ultimate controlling shareholder, Beijing Tong Ren Tang Company Limited, on the Shanghai Stock Exchange.

Significant events and developments

• The announcement is made in compliance with Hong Kong regulatory requirements and references the publication of financial information by the controlling shareholder.

• Shareholders and potential investors are advised to exercise caution when dealing in the securities.

Capital allocation and financing

• The announcement includes the current composition of the Board, listing executive, non-executive, and independent non-executive directors.